{
  "nav": {
    "home": "Home",
    "innovation": "Innovation",
    "roadmap": "Roadmap",
    "contact": "Contact"
  },
  "heroTitle": {
    "line1": "Invest",
    "line2": "in the future",
    "line3": "of contraception"
  },
  "heroDescription": "Andro-Switch: the world's first male thermal contraception medical device.",
  "heroButton": "Become a partner",
  "innovationSubtitle": "Andro-Switch Innovation",
  "innovationTitle": "Revolutionizing contraception",
  "innovationStats": {
    "year": "2027",
    "yearDesc": "Commercial launch planned",
    "market": "1.2B",
    "marketDesc": "Estimated potential market",
    "sideEffects": "0",
    "sideEffectsDesc": "Significant side effects",
    "willingness": "70%",
    "willingnessDesc": "Europeans willing to use the Andro-Switch solution"
  },
  "innovationFeatures": {
    "title1": "Certified technology",
    "desc1": "Innovative solution protected by international patents",
    "title2": "Comprehensive clinical studies",
    "desc2": "Rigorous and transparent scientific validation",
    "title3": "Global impact",
    "desc3": "Enhances women's health and autonomy"
  },
  "autotest": {
    "title1": "Andro-Switch is thought ",
    "title2": "to fit the market",
    "description": "Text to find"
  },
  "cardsSection": {
    "card1Title": "MALE CONTRACEPTION: WHERE DO WE STAND?",
    "card1Subtitle": "Discover the current state of contraceptive solutions",
    "card1Detail": "Explore the current landscape of male contraception, its advancements, and the challenges to overcome for better accessibility.",
    "card2Title": "ADVANCED TECHNOLOGY",
    "card2Subtitle": "An eco-friendly and ethical product, part of a slow-low tech path and short-circuit approach.",
    "card2Detail": "Discover our revolutionary technology that combines efficiency, safety, and accessibility for natural fertility control.",
    "card3Title": "SHARED RESPONSIBILITY",
    "card3Subtitle": "Towards equality in contraceptive responsibility.",
    "card3Detail": "Understand how male contraception is redefining the balance of reproductive responsibilities in modern couples.",
    "card4Title": "CLINICAL TRIALS",
    "card4Subtitle": "Promising results under certification.",
    "card4Detail": "Discover the results of our rigorous clinical trials demonstrating the effectiveness and safety of our solution.",
    "card5Title": "TESTIMONIALS AND ACTIVE COMMUNITY",
    "card5Subtitle": "Inspiring user stories",
    "card5Detail": "Discover authentic testimonials from those who have chosen to take responsibility for their contraception.",
    "card6Title": "CALL FOR MEDICAL ADVANCEMENT",
    "card6Subtitle": "Towards a contraceptive and economic revolution: the urgency of collective action.",
    "card6Detail": "Explore how innovation in male contraception can transform reproductive health and gender equality.",
    "learnMore": "Learn more"
  },
  "visionSection": {
    "title": "Long-term Vision:",
    "description": "Open Andro-Switch to the markets of Europe, the USA, and Canada.",
    "phase1": "Phase 1: Europe",
    "phase1Desc": "Initial launch in European markets with local partners",
    "phase2": "Phase 2: North America",
    "phase2Desc": "Expansion to the United States and Canada",
    "phase3": "Phase 3: Global",
    "phase3Desc": "Worldwide presence with major public health impact",
    "faqTitle1": "What are the obstacles?",
    "faqAns1": "Regulation, social acceptability, and market access",
    "faqTitle2": "How can they be overcome?",
    "faqAns2": "Robust clinical studies and strategic partnerships",
    "faqTitle3": "What impact?",
    "faqAns3": "Revolutionizing access to safe male contraception"
  },
  "roadmapSection": {
    "title": "Strategic Roadmap",
    "subtitle": "Andro-Switch",
    "visionTitle": "Our vision",
    "visionDesc": "Vision to long-term: here's what we've done, here's where we're headed, and this is for all of us!",
    "largeBox": "Roadmap visual box",
    "statsCount": "2",
    "statsDesc": "AI Tools in development for professionals healthcare and users",
    "statsFullDesc": "From current initiatives through worldwide availability, our roadmap spans 2024-2030+ delivering integrated AI solutions, clinical validation, market expansion, and global accessibility.",
    "readMore": "Read More",
    "learnMore": "Learn More",
    "strategicphases":"4 strategic phases",
    "phase1Year": "2024-2025",
    "phase1Title": "Current Phase",
    "phase1Desc": "Global awareness campaign • AI tool development",
    "phase2Year": "2026-2027",
    "phase2Title": "Clinical Expansion",
    "phase2Desc": "Final phase trials • Regulatory approvals",
    "phase3Year": "2028-2029",
    "phase3Title": "Market Preparation",
    "phase3Desc": "Distribution setup • Professional training",
    "phase4Year": "2030+",
    "phase4Title": "Availability",
    "phase4Desc": "Product in pharmacies • SDG impact achieved",
    "timeline1": "2018 - Research and Development",
    "timeline1Desc": "Text to fit.",
    "timeline2": "2020 - International Patent",
    "timeline2Desc": "Text to fit.",
    "timeline3": "2022 - Phase 1 Clinical Trials",
    "timeline3Desc": "Text to fit.",
    "timeline4": "2027 - CE Certification",
    "timeline4Desc": "Text to fit.",
    "timeline5": "2028 - Global Expansion",
    "timeline5Desc": "Text to fit.",
    "calculatorTitle": "Investor Impact Calculator",
    "calculatorDesc": "Visualize the direct impact of your investment on the contraceptive revolution"
  },
  "investorTool": {
    "investmentLabel": "Investment amount",
    "minAmount": "10 K€",
    "maxAmount": "10 M€",
    "educatedWomen": "Educated Women",
    "beneficiaries": "beneficiaries",
    "trainedProfessionals": "Trained Professionals",
    "healthSector": "in health sector",
    "accessibleDevices": "Accessible Devices",
    "projections": "projections",
    "marketPotential": "Market Potential",
    "generation": "generation",
    "impactMessagePrefix": "Your investment of",
    "impactMessageMiddle": "€ creates a direct impact of",
    "impactMessageSuffix": "beneficiaries and change-makers."
  },
  "trustSection": {
    "subtitle": "Our Partners",
    "title": "They Trust Us"
  },
  "collaborationSection": {
    "title": "Let's Collaborate",
    "subtitle": "on the Future",
    "subtitle2": "Together.",
    "description": "We are looking for visionary partners to accelerate the adoption of innovative and accessible contraceptive solutions.",
    "button": "Join Us",
    "partnersTitle": "Partners and Investors",
    "benefit1": "Access to revolutionary technology",
    "benefit2": "Rapidly growing market",
    "benefit3": "Positive societal impact"
  },
  "footerSection": {
    "brandTitle": "Andro-Switch",
    "tagline": "Revolutionizing male contraception for a better future",
    "productTitle": "Product",
    "productAbout": "About",
    "productTechnology": "Technology",
    "productStudies": "Studies",
    "companyTitle": "Company",
    "companyBlog": "Blog",
    "companyCareers": "Careers",
    "companyContact": "Contact",
    "legalTitle": "Legal",
    "legalPrivacy": "Privacy",
    "legalTerms": "Terms of Use",
    "legalNotice": "Legal Notice",
    "copyright": "© 2024 Andro-Switch. All rights reserved.",
    "socialTwitter": "Twitter",
    "socialLinkedin": "LinkedIn",
    "socialFacebook": "Facebook"
  },
  "misc": {
    "back": "Back",
    "toggleMenu": "Toggle mobile menu"
  },
  "gate": {
  "thorem": "THOREME-CORE",
  "title": "Andro-Switch",
  "description1": "The world's first male thermal contraception medical device",
  "description2": "Join the revolution!",
  "inputPlaceholder": "Access code",
  "submitButton": "ENTER THE FUTURE",
  "verifying": "Verifying...",
  "accessNote": "Access reserved for initiates",
  "errorIncorrect": "Incorrect access code"
},
"hud": {
    "card1": {
      "title": "Product",
      "description": "Product Storytelling",
      "biomimicry": "Biomimicry",
      "inspiredBy": "Inspired by nature",
      "thor": "Thor - 3D Torus",
      "goldenRatio": "Golden Ratio",
      "fullDescription": "A revolutionary approach to contraception inspired by natural thermal principles and the perfect symmetry of the golden ratio."
    },
    "card2": {
      "title": "Technology",
      "description": "How does it work?",
      "cleanTech": "Clean Tech",
      "thermalContraception": "Thermal contraception",
      "reversible": "Reversible & Non-invasive",
      "fullDescription": "Advanced thermal technology that works with the body's natural processes, completely reversible and non-invasive."
    },
    "card3": {
      "title": "Society",
      "description": "Strategic alignment",
      "france2030": "France 2030",
      "funding": "€400M for innovation",
      "globalPartners": "FP2030, UNFPA, WHO",
      "fullDescription": "Aligns with France 2030's strategic priorities for innovative medical devices and global SDG commitments."
    },
    "card4": {
      "title": "Market",
      "description": "Contraceptive equity",
      "womensEquity": "Women's Equity",
      "seekingInnovation": "Seeking innovation",
      "mensInterest": "Men's Interest",
      "fullDescription": "Meeting critical demand for contraceptive equity among women while attracting male investor interest."
    },
    "metrics": {
      "card1": [
        { "label": "Concept", "value": "Biomimicry" },
        { "label": "Inspiration", "value": "Thor - 3D Torus" },
        { "label": "Symmetry", "value": "Golden Ratio" },
        { "label": "Innovation", "value": "Thermal" },
        { "label": "Design", "value": "Nature-Inspired" }
      ],
      "card2": [
        { "label": "Type", "value": "Clean Tech" },
        { "label": "Method", "value": "Thermal" },
        { "label": "Reversibility", "value": "100%" },
        { "label": "Invasiveness", "value": "Non-invasive" },
        { "label": "Environmental", "value": "Eco-friendly" }
      ],
      "card3": [
        { "label": "Government", "value": "France 2030" },
        { "label": "Allocation", "value": "€400M" },
        { "label": "Focus", "value": "Medical Innovation" },
        { "label": "Global", "value": "FP2030, UNFPA, WHO" },
        { "label": "SDG", "value": "Universal Access" }
      ],
      "card4": [
        { "label": "Women", "value": "High Demand" },
        { "label": "Equity", "value": "Accessible" },
        { "label": "Men's Interest", "value": "Growing" },
        { "label": "Market Gap", "value": "Significant" },
        { "label": "Revenue", "value": "Substantial" }
      ]
    }
  }
}